Medication info
Positam Extended-Release Tablet 10/100/1000 mg (Dapagliflozin, Sitagliptin, Metformin)

Positam Extended-Release Tablet 10/100/1000 mg (Dapagliflozin, Sitagliptin, Metformin)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletSitagliptin Phosphate Hydrate›128.5mg / 1 tabletDapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Pink oval extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202401772 · Approved 2024.07.23 · Insurance code 671707420

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended dose of this medicine for antidiabetic therapy is 10 mg of dapagliflozin and 100 mg of sitagliptin; the dose of extended-release metformin hydrochloride is determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, take this medicine once daily with a meal, preferably in the evening. If the dose of metformin hydrochloride needs adjustment, adjust it gradually. Patients taking this medicine as 10/100/1000 mg extended-release tablets should take 1 tablet once daily. Patients taking this medicine as 5/50/500 mg, 5/50/750 mg, or 5/50/1000 mg extended-release tablets should take 2 tablets once daily. If adequate glycemic control cannot be achieved with combination therapy of metformin hydrochloride and sitagliptin, the starting dose of this medicine should be dapagliflozin 10 mg, sitagliptin 100 mg, and the current dose of metformin hydrochloride, or a therapeutically equivalent dose. For patients switching from combination therapy with dapagliflozin, sitagliptin, and metformin hydrochloride to this medicine, the dose of this medicine should be the existing dose of each component. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other antihyperglycemic agents. Because changes may cause alterations in glycemic control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it. This medicine may not dissolve completely and may be excreted in the feces. It is not known whether the material excreted in the feces contains the active ingredients of the medicine. If a patient repeatedly reports finding this medicine in the feces, healthcare professionals should assess whether blood glucose is adequately controlled (see Precautions for Use, 5. General Precautions). No dose adjustment is required in patients with mild renal impairment. If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher and below 60 mL/min/1.73m2, this medicine may be used by adjusting the dose of metformin hydrochloride, one of its components, provided the patient tolerates it well and has no other symptoms that may increase the risk of lactic acidosis. The starting dose of extended-release metformin hydrochloride is 500mg or 750 mg once daily; therefore, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. If the estimated glomerular filtration rate (eGFR) decreases to below 45 mL/min/1.73m2, treatment with this medicine should be discontinued immediately. Renal function should be assessed every 3~6 months.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes

View approved original text

This medication is used to help control blood glucose levels in patients with type 2 diabetes. In particular, it assists in conjunction with dietary and exercise therapies when taking dapagliflozin, sitagliptin, and metformin together. This helps effectively manage blood glucose levels. This medication contributes to the prevention of complications by improving blood glucose control.

How to take

Adult dose

The recommended dose of this medicine for antidiabetic therapy is 10 mg of dapagliflozin and 100 mg of sitagliptin; the dose of extended-release metformin hydrochloride is determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, take this medicine once daily with a meal, preferably in the evening. If the dose of metformin hydrochloride needs adjustment, adjust it gradually. Patients taking this medicine as 10/100/1000 mg extended-release tablets should take 1 tablet once daily. Patients taking this medicine as 5/50/500 mg, 5/50/750 mg, or 5/50/1000 mg extended-release tablets should take 2 tablets once daily. If adequate glycemic control cannot be achieved with combination therapy of metformin hydrochloride and sitagliptin, the starting dose of this medicine should be dapagliflozin 10 mg, sitagliptin 100 mg, and the current dose of metformin hydrochloride, or a therapeutically equivalent dose. For patients switching from combination therapy with dapagliflozin, sitagliptin, and metformin hydrochloride to this medicine, the dose of this medicine should be the existing dose of each component. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other antihyperglycemic agents. Because changes may cause alterations in glycemic control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it. This medicine may not dissolve completely and may be excreted in the feces. It is not known whether the material excreted in the feces contains the active ingredients of the medicine. If a patient repeatedly reports finding this medicine in the feces, healthcare professionals should assess whether blood glucose is adequately controlled (see Precautions for Use, 5. General Precautions). No dose adjustment is required in patients with mild renal impairment. If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher and below 60 mL/min/1.73m2, this medicine may be used by adjusting the dose of metformin hydrochloride, one of its components, provided the patient tolerates it well and has no other symptoms that may increase the risk of lactic acidosis. The starting dose of extended-release metformin hydrochloride is 500mg or 750 mg once daily; therefore, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. If the estimated glomerular filtration rate (eGFR) decreases to below 45 mL/min/1.73m2, treatment with this medicine should be discontinued immediately. Renal function should be assessed every 3~6 months.

Precautions

This medication may rarely cause serious allergic reactions due to the sitagliptin component. Therefore, if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur within three months after administration, it should be discontinued immediately and consult a doctor. The medication can cause severe inflammation of the pancreas known as acute pancreatitis. If symptoms such as abdominal pain, vomiting, or nausea occur, you must seek medical attention immediately. The metformin component in this medication can rarely cause lactic acidosis, which could be life-threatening; if severe fatigue, muscle pain, breathing difficulties, abdominal pain, or hypothermia occur, treatment should be stopped immediately and medical care should be sought. This medication should not be administered to patients with moderate to severe renal function impairment or acute kidney disease, and patients with decreased kidney function should have regular kidney function tests before and during administration. Patients with conditions affecting kidney function, such as dehydration, severe infections, heart failure, myocardial infarction, or sepsis should avoid using this medication or use it cautiously. This medication must be discontinued for a certain period before and after examinations using radiologic iodine contrast agents, and should only be resumed after confirming that kidney function is normal. This medication should not be used by patients with type 1 diabetes or a history of diabetic ketoacidosis. The administration of this medication must be temporarily suspended for 48 hours before surgery and until kidney function is restored to normal post-surgery, after which it can be resumed. In patients with reduced fluid volume or at risk of hypotension, blood pressure reduction and worsening kidney function can occur; hence, fluid status and blood pressure should be monitored periodically. This medication may increase the risk of genital and urinary tract infections, so treatment should be sought immediately if symptoms of infection occur. Rarely, this medication may cause severe skin disorders, joint pain, or blistering skin conditions. Consult a doctor if skin rashes or severe joint pain occur. During the use of this medication, be vigilant for symptoms of hypoglycemia, especially when used in combination with other hypoglycemic agents, as this may increase the risk of low blood sugar. Alcohol consumption may increase the risk of lactic acidosis; therefore, excessive alcohol should be avoided while taking this medication. Long-term use of this medication may result in vitamin B12 deficiency, so it is advisable to monitor vitamin B12 levels with regular blood tests. Pregnant women or those with placental function issues should not use this medication, and must consult a doctor if planning to become pregnant or if already pregnant.

Side effects

  • Severe hypersensitivity reaction
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hemorrhagic pancreatitis
  • necrotizing pancreatitis
  • lactic acidosis
  • hypoglycemia
  • vulvovaginitis
Show 204 more
  • balanitis
  • genital infection
  • urinary tract infection
  • fungal infection
  • perineal necrosis
  • decreased fluid volume
  • thirst
  • diabetic ketoacidosis
  • dizziness
  • constipation
  • dry mouth
  • back pain
  • dysuria
  • polyuria
  • nocturia
  • interstitial nephritis
  • elevated hematocrit
  • decreased serum creatinine clearance
  • dyslipidemia
  • elevated serum creatinine
  • elevated blood urea
  • weight loss
  • rash
  • urosepsis
  • pyelonephritis
  • acute kidney injury
  • renal dysfunction
  • gastroesophageal reflux disease
  • epigastric pain
  • diverticulosis
  • bowel perforation
  • chronic pancreatitis
  • hyperglycemia
  • paresthesia
  • cerebral infarction
  • nerve compression
  • sinusitis
  • diverticulitis
  • pelvic inflammatory disease
  • pneumonia
  • pulmonary tuberculosis
  • asthenia
  • pain
  • ligament sprain
  • road traffic accident
  • drug overdose
  • ankle fracture
  • hand fracture
  • pelvic fracture
  • meniscus injury
  • thoracic vertebra fracture
  • tibia fracture
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • cerebral hemorrhage
  • peripheral artery occlusion
  • angina pectoris
  • myocardial infarction
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • anaphylactic reaction
  • acute pyelonephritis
  • chest pain
  • dyspepsia
  • nausea
  • diarrhea
  • vomiting
  • gastritis
  • headache
  • urinary retention
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • decreased appetite
  • dysgeusia
  • palpitations
  • insomnia
  • fatty liver
  • gallbladder polyp
  • tinnitus
  • taste disturbance
  • erythema
  • pruritus
  • urticaria
  • rash
  • dysgeusia
  • drowsiness
  • tension headache
  • carpal tunnel syndrome
  • diabetic neuropathy
  • coma
  • neuralgia
  • peripheral neuropathy
  • sleep disorders
  • syncope
  • tremor
  • bronchitis
  • shingles
  • herpes simplex
  • stye
  • joint abscess
  • laryngitis
  • otitis media
  • periodontal abscess
  • rhinitis
  • onychomycosis
  • edema
  • fever
  • facial edema
  • facial pain
  • warmth
  • flu-like symptoms
  • vaginal discharge
  • menstrual irregularities
  • pruritus
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • muscle weakness
  • myalgia
  • osteoarthritis
  • ligament sprain
  • diabetic retinopathy
  • cough
  • dyspnea
  • orthostatic hypotension
  • anxiety disorder
  • nocturnal enuresis
  • elevated blood lactate
  • lymphocytopenia
  • elevated serum triglycerides
  • increased low-density lipoprotein
  • hyperglycemia
  • thrombocytopenia
  • vesicular bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • sweating
  • coin-like eczema
  • eczema
  • hyperkeratosis
  • skin lesion
  • flank pain
  • muscle fiber pain
  • limb discomfort
  • muscle cramp
  • musculoskeletal discomfort
  • osteoporosis
  • contusion
  • orbital fracture
  • foot fracture
  • gastrointestinal foreign body
  • laceration
  • ligament rupture
  • skin abrasion
  • tendon rupture
  • dry eyes
  • eye pain
  • retinal disorders
  • visual impairment
  • blepharitis
  • cataract
  • conjunctival edema
  • allergic conjunctivitis
  • conjunctivitis
  • diplopia
  • eyelid edema
  • keratitis
  • ocular hypertension
  • visual impairment
  • vitreous floaters
  • oropharyngeal pain
  • allergic rhinitis
  • asthma
  • vocal cord dysfunction
  • epistaxis
  • sleep apnea syndrome
  • wheezing
  • atherosclerosis
  • flushing
  • peripheral coldness
  • varicose veins
  • vascular headache
  • angina pectoris
  • atrial fibrillation
  • diastolic dysfunction
  • anxiety disorder
  • auditory hallucinations
  • suicide attempt
  • bile duct stones
  • cholangitis
  • liver cyst
  • dizziness
  • anal genital warts
  • gastric adenoma
  • neuroma
  • male reproductive hormone deficiency
  • thyroid cyst
  • thyroid nodule
  • food allergy
  • erythrocytosis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent exposure to air or moisture. It is crucial to maintain storage temperatures between 1 degree and 30 degrees Celsius. This way, the efficacy of the medication can be safely preserved.

Appearance and packaging

Appearance

Pink oval extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.